metoclopramide has been researched along with Barrett Epithelium in 8 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This long-term study in a patient with Barrett's esophagus showed 1) that cimetidine can be effective in treating such patients; 2) the prophylactic value of multitherapy as a maintenance regimen, and 3) the importance of careful follow-up." | 5.27 | Prolonged cimetidine therapy in ulcerated Barrett's columnar-lined esophagus. ( Avidor, I; Delpre, G; Glanz, I; Kadish, U, 1984) |
| "Sixty-seven patients with Barrett's esophagus have been prospectively followed over an average of 36 months (range 6 to 76 months) with standardized endoscopic observation and biopsies of the length of columnar epithelium." | 1.28 | Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. ( Aickin, M; Fennerty, MB; Garewal, HS; Sampliner, RE, 1990) |
| "This long-term study in a patient with Barrett's esophagus showed 1) that cimetidine can be effective in treating such patients; 2) the prophylactic value of multitherapy as a maintenance regimen, and 3) the importance of careful follow-up." | 1.27 | Prolonged cimetidine therapy in ulcerated Barrett's columnar-lined esophagus. ( Avidor, I; Delpre, G; Glanz, I; Kadish, U, 1984) |
| "Gastroesophageal reflux (GER) disease is a common, multifactorial medical condition that may be difficult to treat." | 1.27 | A critical review of current medical therapy for gastroesophageal reflux disease. ( Richter, JE, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wesdorp, IC | 1 |
| Delpre, G | 1 |
| Kadish, U | 1 |
| Glanz, I | 1 |
| Avidor, I | 1 |
| Fahrländer, H | 1 |
| McDougall, NI | 1 |
| Johnston, BT | 1 |
| Kee, F | 1 |
| Collins, JS | 1 |
| McFarland, RJ | 1 |
| Love, AH | 1 |
| Mascarenhas, MR | 1 |
| McGowan, KL | 1 |
| Ruchelli, E | 1 |
| Athreya, B | 1 |
| Altschuler, SM | 1 |
| Sampliner, RE | 1 |
| Garewal, HS | 1 |
| Fennerty, MB | 1 |
| Aickin, M | 1 |
| Richter, JE | 1 |
| Lieberman, DA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study[NCT02081404] | 98 participants (Actual) | Interventional | 2009-03-01 | Completed | |||
| Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study[NCT01574573] | 52 participants (Actual) | Interventional | 2009-06-30 | Terminated (stopped due to Closed due to lack of recruitment) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for metoclopramide and Barrett Epithelium
| Article | Year |
|---|---|
Medical therapy for chronic reflux esophagitis. Long-term follow-up.
Topics: Barrett Esophagus; Chronic Disease; Cimetidine; Clinical Trials as Topic; Drug Therapy, Combination; | 1987 |
7 other studies available for metoclopramide and Barrett Epithelium
| Article | Year |
|---|---|
Treatment of reflux oesophagitis.
Topics: Alginates; Aluminum Hydroxide; Antacids; Anti-Ulcer Agents; Barrett Esophagus; Bethanechol Compounds | 1982 |
Prolonged cimetidine therapy in ulcerated Barrett's columnar-lined esophagus.
Topics: Aged; Aluminum Hydroxide; Barrett Esophagus; Cimetidine; Drug Combinations; Drug Therapy, Combinatio | 1984 |
[Pathophysiology, clinical aspects and therapy of gastro-esophageal reflux disease].
Topics: Antacids; Barrett Esophagus; Candidiasis; Cholic Acids; Cimetidine; Diagnosis, Differential; Endosco | 1981 |
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea | 1996 |
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea | 1996 |
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea | 1996 |
Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Barrett Esophagus; Cisapride; Deglutition Disorders; Disea | 1996 |
Acremonium infection of the esophagus.
Topics: Acremonium; Barrett Esophagus; Child, Preschool; Cimetidine; Connective Tissue Diseases; Esophageal | 1997 |
Lack of impact of therapy on extent of Barrett's esophagus in 67 patients.
Topics: Adult; Aged; Aged, 80 and over; Barrett Esophagus; Esophagoscopy; Esophagus; Female; Follow-Up Studi | 1990 |
A critical review of current medical therapy for gastroesophageal reflux disease.
Topics: Alginates; Antacids; Barrett Esophagus; Bethanechol; Bethanechol Compounds; Cimetidine; Gastroesopha | 1986 |